Who owns BioCryst Pharmaceuticals?

Key details on BioCryst Pharmaceuticals (Ticker: BCRX)

Who owns BioCryst Pharmaceuticals?

Is BCRX a good stock to own? Find out who bought BioCryst Pharmaceuticals, who sold BioCryst Pharmaceuticals (BCRX) stock, and who holds a large position in BioCryst Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baker Bros. Advisors 10.71M $130.28M Dec. 31, 2014
FMR 10.65M $104.12M Sept. 30, 2014
Wellington Management Company 7.39M $89.85M Dec. 31, 2014
RA Capital Management 7.05M $85.73M Dec. 31, 2014
BlackRock Fund Advisors 2.80M $34.10M Dec. 31, 2014
STATE STREET CORPORATION 2.79M $33.93M Dec. 31, 2014
Vanguard 2.28M $27.78M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 1.91M $23.26M Dec. 31, 2014
VHCP Management 1.74M $21.21M Dec. 31, 2014
D. E. Shaw & Co 1.67M $20.31M Dec. 31, 2014
T. Rowe Price Associates 1.58M $16.75M March 31, 2014
QVT Financial 1.25M $15.15M Dec. 31, 2014
TPG Group Holdings 1.16M $12.30M March 31, 2014
TPG Capital 1.16M $3.21M Sept. 30, 2011
Deerfield Management Company 907920 $9.61M March 31, 2014
NORTHERN TRUST 839066 $10.19M Dec. 31, 2014
Cormorant Asset Management 800000 $9.73M Dec. 31, 2014
Driehaus Capital Management 702175 $2.98M Sept. 30, 2012
SUSQUEHANNA INTERNATIONAL 626000 $6.12M Sept. 30, 2014
Millennium Management 589752 $6.24M March 31, 2014
Connor, Clark & Lunn Investment Management 528098 $6.17M March 31, 2014
Barclays 516100 $2.49M March 31, 2012
Technical Financial Services 499516 $3.80M Dec. 31, 2013
MORGAN STANLEY 491034 $6.26M June 30, 2014
AQR Capital Management 475435 $5.78M Dec. 31, 2014
Charles Schwab Investment Management 450021 $4.40M Sept. 30, 2014
Jennison Associates 450000 $3.28M Sept. 30, 2013
Geode Capital Management 419905 $5.11M Dec. 31, 2014
BOGLE INVESTMENT MANAGEMENT L P /DE/ 386089 $2.81M Sept. 30, 2013

Who sold BioCryst Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
BAM Capital Dec. 31, 2010 861485 $4.45M